A Comment on Metformin and COVID-19 with Regard to "Metformin Use Is Associated with a Decrease in the Risk of Hospitalization and Mortality in COVID-19 Patients with Diabetes: A Population-Based Study in Lombardy" - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Diabetes, Obesity and Metabolism Année : 2022

A Comment on Metformin and COVID-19 with Regard to "Metformin Use Is Associated with a Decrease in the Risk of Hospitalization and Mortality in COVID-19 Patients with Diabetes: A Population-Based Study in Lombardy"

(1, 2) , (3) , (4) , (1, 2)
1
2
3
4

Dates et versions

hal-03746083 , version 1 (04-08-2022)

Licence

Paternité - CC BY 4.0

Identifiants

Citer

Abdallah Al-Salameh, Nicolas Wiernsperger, Bertrand Cariou, Jean-Daniel Lalau. A Comment on Metformin and COVID-19 with Regard to "Metformin Use Is Associated with a Decrease in the Risk of Hospitalization and Mortality in COVID-19 Patients with Diabetes: A Population-Based Study in Lombardy". Diabetes, Obesity and Metabolism, 2022, 24 (9), pp.1888--1893. ⟨10.1111/dom.14746⟩. ⟨hal-03746083⟩
27 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More